December 22, 2005 by TP Admin
Posted in
Bayer HealthCare AG announced Tuesday that the Food and Drug Administration approved Nexavar (sorafenib tosylate) for treating advanced kidney cancer in adults. Nexavar is co-developed by Bayer and Onyx Pharmaceuticals, Inc.
Nexavar tablets will be available immediately.
For more information see FDA News Release - December 20, 2005 and Bayer Press Release.
